During the last three months, 16 analysts shared their evaluations of Marathon Oil MRO, revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 5 | 5 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 2 | 3 | 0 | 0 |
| 2M Ago | 3 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $32.75, along with a high estimate of $45.00 and a low estimate of $26.00. This upward trend is evident, with the current average reflecting a 5.0% increase from the previous average price target of $31.19.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Marathon Oil among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Devin McDermott | Morgan Stanley | Raises | Equal-Weight | $27.00 | $26.00 |
| Paul Cheng | Scotiabank | Raises | Sector Outperform | $45.00 | $35.00 |
| Betty Jiang | Barclays | Announces | Overweight | $35.00 | - |
| Neal Dingmann | Truist Securities | Raises | Buy | $36.00 | $35.00 |
| Devin McDermott | Morgan Stanley | Raises | Equal-Weight | $26.00 | $24.00 |
| Neil Mehta | Goldman Sachs | Raises | Neutral | $30.00 | $26.50 |
| Nitin Kumar | Mizuho | Raises | Neutral | $31.00 | $28.00 |
| Derrick Whitfield | Stifel | Lowers | Buy | $36.00 | $39.00 |
| Bill Selesky | Argus Research | Announces | Buy | $31.00 | - |
| Subash Chandra | Benchmark | Raises | Buy | $32.00 | $25.00 |
| Roger Read | Wells Fargo | Raises | Overweight | $36.00 | $32.00 |
| Josh Silverstein | UBS | Lowers | Neutral | $27.00 | $28.00 |
| Scott Hanold | RBC Capital | Maintains | Outperform | $33.00 | - |
| Neal Dingmann | Truist Securities | Lowers | Buy | $35.00 | $38.00 |
| John Freeman | Raymond James | Lowers | Strong Buy | $32.00 | $35.00 |
| Mark Lear | Piper Sandler | Lowers | Overweight | $32.00 | $34.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Marathon Oil. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Marathon Oil compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Marathon Oil's stock. This comparison reveals trends in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Marathon Oil's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Marathon Oil analyst ratings.
All You Need to Know About Marathon Oil
Marathon is an independent exploration and production company primarily focusing on unconventional resources in the United States. At the end of 2022, the company reported net proved reserves of 1.3 billion barrels of oil equivalent. Net production averaged 343 thousand barrels of oil equivalent per day in 2022 at a ratio of 70% oil and NGLs and 30% natural gas.
Understanding the Numbers: Marathon Oil's Finances
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, Marathon Oil faced challenges, resulting in a decline of approximately -1.12% in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: Marathon Oil's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 25.05%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Marathon Oil's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.54%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 2.01%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.48, Marathon Oil adopts a prudent financial strategy, indicating a balanced approach to debt management.
The Core of Analyst Ratings: What Every Investor Should Know
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
